Effector Cell

Antigen-specific T cells conditioned with MDSC display a surprising increased anti-tumor activity after adoptive T cell-based immunotherapy
Patrick Raber, Paul Thevenot, Rosa Sierra, Paulo C Rodriguez

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P413; DOI: 10.1186/2051-1426-3-S2-P413
Generation and utilization of polyfunctional anti-tumor CD4+ T cells
Gang Zhou, Zhi-Chun Ding

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P63; DOI: 10.1186/2051-1426-3-S2-P63
IL7 signaling confers polyfunctionality to antitumor CD4+ T cells
Gang Zhou, Zhi-Chun Ding

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P43; DOI: 10.1186/2051-1426-2-S3-P43
Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells
Sandrine Valsesia-Wittmann, Beatrice Clemenceau, Anne-Catherine Jallas, Jean-Yves Blay, Aurelien Marabelle, Christophe Caux, Henri Vie

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P176; DOI: 10.1186/2051-1426-1-S1-P176
P72. Transgenic expression of a chimeric signaling receptor to facilitate T cell costimulation in the tumour environment
R Schlenker, M Leisegang, W Uckert, E Noessner

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P46; DOI: 10.1186/2051-1426-2-S2-P46

Main menu